Healthcare -
Biotechnology - NASDAQ - US
$ 8.03
-0.623 %
$ 178 M
Market Cap
-3.68
P/E
INMB - STOCK-BASED COMPENSATION
Stock-based Compensation INMB - INmune Bio, Inc.
7.37 M
LAST VALUE
23.95%
2 YEAR CAGR
-5.93%
5 YEAR CAGR
0.00%
10 YEAR CAGR